Clinical Trials Browser

Nasopharyngeal Carcinoma, Hypoxia, Nasopharyngeal Neoplasms

NCT03547388 2020-05-05

GKH-TMM

Phase 1 Completed

10 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hyperthermia, Hypoxia, Head and Neck Neoplasms, Recurrence

NCT02976883 2019-01-11

OXYPET

Phase 2 Completed

8 enrolled

Head & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Lung Neoplasms

NCT00395109 2017-08-28

PET/CT to Image Hypoxia in Head and Neck Tumours

Phase EARLY_PHASE1 Completed

17 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms, Neoplasms

NCT01347281 2017-01-30

PET With [18F]HX4 in Head and Neck Cancer

Phase NA Completed

23 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT01075399 2013-08-30

HX4-200

Phase 2 Completed

50 enrolled 7 charts

GastrointestinalGynecologicHead & NeckThoracic

Hypoxia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Rectal Neoplasms

NCT01213030 2012-09-25

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Phase 1/2 Completed

12 enrolled

GastrointestinalHead & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms

NCT00884520 2010-03-16

VM4-037

Phase EARLY_PHASE1 Completed

16 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Hypoxia, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms

Clinical Trials

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

GKH-TMM

OXYPET

PET/CT to Image Hypoxia in Head and Neck Tumours

PET With [18F]HX4 in Head and Neck Cancer

HX4-200

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

VM4-037